Pharma Articles
Renowned pharmaceutical firm executives and other experts from around the world write articles on current topics in the industry. The section of articles on the pharmaceutical sector focuses on contemporary and expanding challenges in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
GLP-1 Receptor Agonists in Obesity Care: Clinical Promise, Nutritional Challenges, and Real-World Implications
The global burden of obesity has reached unprecedented levels driving an urgent need for effective and scalable therapeutic strategies In recent years glucagonlike peptide GLP receptor agonists have emerged as a transformative pharmacological option offering clinically meaningful weight reduction al...B2B Pharmaceutical Marketing in the USA: Strategies, Channels, and Emerging Trends
The pharmaceutical marketing in the United States to businesses has developed into a personalized field of study that is defined by stringent regulations timeintensive sales cycle and higher awareness in the clientele As opposed to consumeroriented advertising in the pharmaceutical industry BB pharm...Pharma Supply Chain Digitalization: 7 Strategies to Boost Transparency and Efficiency in 2026
The pharmaceutical sector is passing into a stage of definition in which the operational sustainability regulatory visibility and patient safety are directly associated with digital maturity With the growing interconnectedness of healthcare systems across the globe and the growing regulation intensi...AI in Pharma Supply Chain: Optimizing Logistics and Inventory Management with 2026 Trends
Pharmaceutical supply chain is moving into a radical transformation stage With the increasing volatility in the global market in drug demand regulatory audit as well as the pressure on cost is becoming difficult and the traditional supply chain model is not enough Artificial intelligence in turn is...The Chiral Blind Spot: Why AI in Drug Discovery Must Learn to See in 3D
Artificial intelligence in life sciences is attracting unprecedented investment Generative models and deep learning platforms are positioned as tools to compress discovery timelines and expand chemical search space Yet a core scientific constraint remains underaddressed Many widely used AI workflows...Best Practices for Pharma Quality Control in US Continuous Manufacturing
The pharmaceutical sector of the United States is experiencing an enormous change where the manufacturers get away with the continuous manufacturing pharma models of production instead of the past batch production models This change is necessitated by the fact that enhanced efficiency shortening of...How Telehealth Is Transforming Access to Care in Chronic Disease Management
Telehealth is more than a remote consultation tool Its a permanent system that supports longterm disease monitoring fosters continuous patient engagement and provides an unprecedented platform for boosting treatment adherence This shift creates new value streams for pharmaceutical companies demandin...Pharma Smart Manufacturing: Leveraging IoT and Digital Twins for Next-Gen Production
There is a paradigm shift in the pharmaceutical sector as the need to develop individualized treatment quicker drug approvals and improved regulations to be followed continue to increase globally Old production models that depend greatly on manual control and responsive quality management are not ap...Pharmaceutical Supply Chain Trends: Innovations, Best Practices, and Future Outlook
Pharmaceutical supply chain is important to guarantee timely safe and quality medicines to patients In comparison to traditional supply chains pharmaceutical supply chain is very strict temperature sensitive and risky in nature where accuracy is demanded in procurement manufacturing storage and dist...How Regulatory Intelligence Drives Competitive Advantage in Pharma
In the present environment of hypercompetition in the pharmaceutical industry it goes beyond scientific innovation to succeed With the world markets being more regulated and the channels of approval becoming more sophisticated pharmaceutical firms are being pressured to make quicker smarter and more...
